Allergy Therapeutics plc (LON:AGY – Get Free Report) shares passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 1.76 ($0.02) and traded as high as GBX 1.80 ($0.02). Allergy Therapeutics shares last traded at GBX 1.80 ($0.02), with a volume of 638,958 shares changing hands.
Allergy Therapeutics Price Performance
The stock has a market cap of £82.82 million, a price-to-earnings ratio of -22.50, a P/E/G ratio of -30.70 and a beta of 1.07. The company has a 50 day simple moving average of GBX 1.76 and a 200-day simple moving average of GBX 3.16. The company has a current ratio of 1.79, a quick ratio of 1.48 and a debt-to-equity ratio of 25.75.
In related news, insider Zheqing Shen acquired 247,935,056 shares of the firm’s stock in a transaction dated Thursday, November 9th. The stock was bought at an average price of GBX 1 ($0.01) per share, for a total transaction of £2,479,350.56 ($3,101,902.36). 87.89% of the stock is owned by corporate insiders.
About Allergy Therapeutics
Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics.
- Five stocks we like better than Allergy Therapeutics
- The How and Why of Investing in Biotech Stocks
- The most upgraded stocks in November have two things in common
- Investing in large cap stocks: Diving into big caps
- Monday.com rocked earnings like it’s the weekend
- Market Cap Calculator: How to Calculate Market Cap
- Plan to own one retailer? Make it this one
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.